Contact

Contact Progen Diagnostics

Discuss Uromonitor adoption with Progen Diagnostics.

Speak to Progen Diagnostics about Uromonitor® evidence, implementation, pathway modelling and adoption across NHS, private provider or laboratory settings.

Clinical evidence Request evidence summaries and supporting material.
Implementation Discuss pathway use, laboratory workflow and governance.
Partnership Explore NHS, private provider or laboratory adoption.
Healthcare decision-makers discussing diagnostic implementation in a professional meeting room
Clinical implementation planning with pathway documents and diagnostic reports
Who Should Contact

For healthcare teams considering pathway change.

Progen Diagnostics can support conversations with clinicians, urology teams, laboratories, NHS organisations, private providers and operational decision-makers.

Clinical teams Discuss intended use, patient selection and clinical governance.
Operational teams Review pathway modelling, capacity pressure and implementation design.
Laboratories and providers Explore testing workflow, reporting, quality control and adoption routes.
Email info@progendiagnostics.com
Enquiry Form

Start the conversation.

Send a short enquiry and Progen Diagnostics can follow up with the right evidence, implementation information or pathway discussion.

This form is for healthcare, laboratory, provider and implementation enquiries. Progen Diagnostics does not provide emergency medical advice through this website.

Implementation Support

What Progen can help with.

Adoption of Uromonitor should be evidence-led, clinically governed and operationally realistic. Progen Diagnostics can support serious healthcare teams with the materials required to evaluate and implement the pathway properly.

Evidence review Clinical evidence summaries, supporting papers and intended-use explanation.
Pathway design Discussion around surveillance flow, triage rules and cystoscopy prioritisation.
Capacity modelling Support for understanding operational impact, cost and clinical time pressure.
Governance planning Implementation boundaries, audit approach, reporting workflow and escalation rules.
Diagnostics Partner

Built for serious clinical adoption.

Progen Diagnostics supports UK and Irish healthcare providers with the adoption of Uromonitor as a non-invasive molecular urine test for bladder cancer surveillance and pathway triage.

Scientist and healthcare professional reviewing laboratory workflow and reporting process